Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

TThis is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

alt text

In-home visits to reduce patient burden and improve retention in clinical trials

The FDA guidance advised sponsors to evaluate if alternative methods, such as virtual visits or alternative locations could be used for safety assessments to protect patients during COVID-19 pandemic.

Sponsors had already started to explore the opportunity of including in-home visits but the current conditions have heightened the need to consider decentralised and hybrid trials to reduce patient burden and increase retention to minimise disruption.

Join our experts to hear more about this approach and the value it brings to patients and sponsors

  • The benefits of In-home visits
  • Patient population and study type considerations
  • The scope of services and tests feasible
  • Best practice in planning and execution
  • Regulatory guidance and steps required to integrate this option into studies


alt text

Nicki M. Norris

CEO, Symphony Clinical Research,
Part of ICON plc.

Nicki brings more than thirty years of experience in healthcare, healthcare services and clinical research organizations. Prior to joining Symphony in 2009, Nicki led the College of American Pathologists (CAP), a laboratory accreditation company and professional society. She was the Chief Operating Officer for the Institute for Transfusion Medicine (ITxM), a blood collection and processing organization. Prior to this she was General Manager for Everest Healthcare Services organization, a high-growth dialysis services company. Nicki was at Baxter Healthcare Corporation for 20 years, where she held several positions of increasing responsibility crossing multiple functional areas and business units, including product management, new product development, marketing, operations, strategic planning, financial management, sales management, R&D and employee benefits.

Nicki has a BS in Finance and an MBA from the University of Illinois at Urbana-Champaign. She also successfully sat for the CPA exam after completing the Professional Accounting Program at Northwestern University.

alt text

Donna Mackey, MS

Senior Director of Clinical Operations
Alnylam Pharmaceuticals

Donna Mackey has over 25 years of clinical research experience and has spent the last 15+ years focused on developing treatments for patients with rare medical conditions. She is currently Senior Director of Clinical Operations at Alnylam Pharmaceuticals where she is responsible for clinical oversight of several rare disease programs utilizing a new class of therapies based on RNA interference. Previously she was with Synageva BioPharma and Genzyme Corporation as the Therapeutic Clinical Leader for lysosomal storage disease programs well as a Global Team Leader. Prior to joining Genzyme, Ms. Mackey was with Quintiles and directed the local Cardiovascular Therapeutics group. Ms. Mackey is a graduate of McGill University with a degree in Physiology. She has also received a Master of Science degree in Management.

alt text

David Morse

Vice President, Global Regulatory Affairs and Consulting
ICON plc

David provides operational oversight and strategic planning for ICON’s Global Regulatory Affairs services group. He has over 30 years of experience in Regulatory Affairs, including over a decade in the clinical research services industry and nearly two decades at the US FDA. David’s experience covers all phases of product development, from discovery and translational development through to marketing application preparation and post-marketing product life-cycle management. Much of David’s experience has emphasised products for serious and life-threatening disease indications, accelerated development strategies in international trials, and the use of expedited programs in product review. He has multiple publications and presentations regarding product review, the development of new regulations, and the communication of risk to special populations. David has dual Baccalaureates in Biology and Psychology, and a PhD in Neuroscience.

Hosted by

Maire Gerrard
Custom Content Writer
Informa Pharma Intelligence

Complete the form to access on demand!


By completing this form you agree ICON plc may contact you directly about industry news, products, services and events that may be of interest to you subject to their privacy policy.